Literature DB >> 22206967

Functional brain networks and abnormal connectivity in the movement disorders.

Kathleen L Poston1, David Eidelberg.   

Abstract

Clinical manifestations of movement disorders, such as Parkinson's disease (PD) and dystonia, arise from neurophysiological changes within the cortico-striato-pallidothalamocortical (CSPTC) and cerebello-thalamo-cortical (CbTC) circuits. Neuroimaging techniques that probe connectivity within these circuits can be used to understand how these disorders develop as well as identify potential targets for medical and surgical therapies. Indeed, network analysis of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has identified abnormal metabolic networks associated with the cardinal motor symptoms of PD, such as akinesia and tremor, as well as PD-related cognitive dysfunction. More recent task-based and resting state functional magnetic resonance imaging studies have reproduced several of the altered connectivity patterns identified in these abnormal PD-related networks. A similar network analysis approach in dystonia revealed abnormal disease related metabolic patterns in both manifesting and non-manifesting carriers of dystonia mutations. Other multimodal imaging approaches using magnetic resonance diffusion tensor imaging in patients with primary genetic dystonia suggest abnormal connectivity within the CbTC circuits mediate the clinical manifestations of this inherited neurodevelopmental disorder. Ongoing developments in functional imaging and future studies in early patients are likely to enhance our understanding of these movement disorders and guide novel targets for future therapies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22206967      PMCID: PMC3489159          DOI: 10.1016/j.neuroimage.2011.12.021

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  102 in total

Review 1.  Dystonia genotypes, phenotypes, and classification.

Authors:  Susan B Bressman
Journal:  Adv Neurol       Date:  2004

2.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.

Authors:  Simon J G Lewis; Aleksandra Slabosz; Trevor W Robbins; Roger A Barker; Adrian M Owen
Journal:  Neuropsychologia       Date:  2004-12-21       Impact factor: 3.139

5.  Intermuscular coherence in Parkinson's disease: relationship to bradykinesia.

Authors:  P Brown; J Marsden; L Defebvre; F Cassim; P Mazzone; A Oliviero; M G Altibrandi; V Di Lazzaro; P Limousin-Dowsey; V Fraix; P Odin; P Pollak
Journal:  Neuroreport       Date:  2001-08-08       Impact factor: 1.837

6.  Network correlates of the cognitive response to levodopa in Parkinson disease.

Authors:  P J Mattis; C C Tang; Y Ma; V Dhawan; D Eidelberg
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

7.  Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

Authors:  A Priori; G Foffani; A Pesenti; F Tamma; A M Bianchi; M Pellegrini; M Locatelli; K A Moxon; R M Villani
Journal:  Exp Neurol       Date:  2004-10       Impact factor: 5.330

8.  Functional connectivity of cortical motor areas in the resting state in Parkinson's disease.

Authors:  Tao Wu; Xiangyu Long; Liang Wang; Mark Hallett; Yufeng Zang; Kuncheng Li; Piu Chan
Journal:  Hum Brain Mapp       Date:  2010-08-25       Impact factor: 5.038

9.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

10.  Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia.

Authors:  Neil J Risch; Susan B Bressman; Geetha Senthil; Laurie J Ozelius
Journal:  Am J Hum Genet       Date:  2007-04-27       Impact factor: 11.025

View more
  41 in total

1.  Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Authors:  Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-08       Impact factor: 9.236

2.  Involuntary movement in pediatric moyamoya disease patients: consideration of pathogenetic mechanism using neuroimaging studies.

Authors:  Ji Yeoun Lee; Seung-Ki Kim; Kyu-Chang Wang; Jong Hee Chae; Jung-Eun Cheon; Jung Won Choi; Ji Hoon Phi; Byung Chan Lim; Ki Joong Kim; In-One Kim; Yong Seung Hwang; Young Seob Chung
Journal:  Childs Nerv Syst       Date:  2013-12-12       Impact factor: 1.475

Review 3.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

4.  Longitudinal Study of Gray Matter Changes in Parkinson Disease.

Authors:  X Jia; P Liang; Y Li; L Shi; D Wang; K Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-10       Impact factor: 3.825

Review 5.  Functional brain networks in movement disorders: recent advances.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

6.  Structural covariance networks of striatum subdivision in patients with Parkinson's disease.

Authors:  Kun-Hsien Chou; Wei-Che Lin; Pei-Lin Lee; Nai-Wen Tsai; Yung-Cheng Huang; Hsiu-Ling Chen; Kuei-Yueh Cheng; Pei-Chin Chen; Hung-Chen Wang; Tsu-Kung Lin; Shau-Hsuan Li; Wei-Ming Lin; Cheng-Hsien Lu; Ching-Po Lin
Journal:  Hum Brain Mapp       Date:  2014-12-31       Impact factor: 5.038

7.  Levodopa modulates small-world architecture of functional brain networks in Parkinson's disease.

Authors:  Brian D Berman; Jason Smucny; Korey P Wylie; Erika Shelton; Eugene Kronberg; Maureen Leehey; Jason R Tregellas
Journal:  Mov Disord       Date:  2016-07-27       Impact factor: 10.338

8.  Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8.

Authors:  Mwiza Ushe; Joel S Perlmutter
Journal:  Mov Disord       Date:  2012-12       Impact factor: 10.338

9.  Patterns of Cortical Synchronization in Isolated Dystonia Compared With Parkinson Disease.

Authors:  Svjetlana Miocinovic; Coralie de Hemptinne; Salman Qasim; Jill L Ostrem; Philip A Starr
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

10.  Exercise Therapy for Parkinson's Disease: Pedaling Rate Is Related to Changes in Motor Connectivity.

Authors:  Chintan Shah; Erik B Beall; Anneke M M Frankemolle; Amanda Penko; Michael D Phillips; Mark J Lowe; Jay L Alberts
Journal:  Brain Connect       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.